Articles related to ANTIPSYCHOTICS

Clozapine did not show superior efficacy compared to second-generation antipsychotics in treatment-resistant schizophrenia.

Co-commencing metformin with antipsychotics can reduce weight gain by over 4 kg compared to controls, providing a concrete strategy for managing one of psychiatry’s most challenging side effects.

Expert psychiatric nurse practitioners stress the importance of familiarity with product inserts for each long-acting injectable antipsychotic to effectively manage missed doses in schizophrenia treatment.

Erzofri offers a new once-monthly injectable option for treating schizophrenia and schizoaffective disorder, potentially improving medication adherence for some patients.

Schizophrenia is a chronic brain disorder characterized by hallucinations, delusions, and cognitive impairments, affecting up to 1 percent of the global population. Understanding its symptoms, causes, and treatment options is crucial for effective patient care.

Effective management of tardive dyskinesia requires early prevention with second-generation antipsychotics and the use of VMAT2 inhibitors like deutetrabenazine and valbenazine, which offer the highest quality evidence for reducing symptoms.